SLC45A3 antibody (AA 351-450) (Biotin)
Quick Overview for SLC45A3 antibody (AA 351-450) (Biotin) (ABIN718198)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 351-450
-
Cross-Reactivity
- Rat
-
Predicted Reactivity
- Human,Mouse,Dog,Cow,Sheep,Pig,Arabidopsis Thaliana
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human PCANAP2
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB 1:300-5000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C for 12 months.
-
Expiry Date
- 12 months
-
-
- SLC45A3 (Solute Carrier Family 45, Member 3 (SLC45A3))
-
Alternative Name
- PCANAP2
-
Background
-
Synonyms: IPCA 2, IPCA 8, IPCA6, PCANAP2, PCANAP6, PCANAP8, Prostate cancer associated gene 2, Prostate cancer associated gene 6, Prostate cancer associated gene 8, Prostate cancer associated protein 2, Prostate cancer associated protein 6, Prostate cancer associated protein 8, Prostate cancer-associated protein 6, Prostein, PRST, S45A3_HUMAN, Slc45a3, Solute carrier family 45 member 3.
Background: PSA, prostate specific antigen, is the classic indicator for transformed pro-state tissue, however, in addition to being upregulated in prostate cancer, PSA is also upregulated in non-malignant conditions, such as benign prostatic hyperplasia. Prostein, also designated Prostate cancer-associated protein 6, is a prostate-specific, 553 amino acid transmembrane protein that is upregulated by androgens. It is considered a marker for prostate cells since it is expressed in all prostatic glandular cells as well as in normal and cancerous prostate tissues. Since it is able to elicit a tumor-directed cytotoxic T cell response, Prostein may be used as a target for the development of PSA- and T cell-based therapeutic strategies for prostate cancer.
-
Gene ID
- 85414
Target
-